- Home
- AUNA vs ALEC Comparison
AUNA vs ALEC Comparison
Compare AUNA & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUNA
- ALEC
- Stock Information
- Founded
- AUNA 1989
- ALEC 2013
- Country
- AUNA Luxembourg
- ALEC United States
- Employees
- AUNA N/A
- ALEC N/A
- Industry
- AUNA
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUNA
- ALEC Health Care
- Exchange
- AUNA NYSE
- ALEC Nasdaq
- Market Cap
- AUNA 521.9M
- ALEC 176.3M
- IPO Year
- AUNA 2024
- ALEC 2019
- Fundamental
- Price
- AUNA $7.77
- ALEC $1.64
- Analyst Decision
- AUNA Strong Buy
- ALEC Buy
- Analyst Count
- AUNA 4
- ALEC 6
- Target Price
- AUNA $13.40
- ALEC $11.75
- AVG Volume (30 Days)
- AUNA 42.3K
- ALEC 1.4M
- Earning Date
- AUNA 11-19-2024
- ALEC 02-25-2025
- Dividend Yield
- AUNA N/A
- ALEC N/A
- EPS Growth
- AUNA N/A
- ALEC N/A
- EPS
- AUNA N/A
- ALEC N/A
- Revenue
- AUNA $1,168,151,825.00
- ALEC $61,508,000.00
- Revenue This Year
- AUNA $17.06
- ALEC N/A
- Revenue Next Year
- AUNA $9.63
- ALEC $45.42
- P/E Ratio
- AUNA N/A
- ALEC N/A
- Revenue Growth
- AUNA 18.72
- ALEC N/A
- 52 Week Low
- AUNA $6.17
- ALEC $1.61
- 52 Week High
- AUNA $10.85
- ALEC $7.78
- Technical
- Relative Strength Index (RSI)
- AUNA N/A
- ALEC 29.31
- Support Level
- AUNA N/A
- ALEC $1.68
- Resistance Level
- AUNA N/A
- ALEC $2.16
- Average True Range (ATR)
- AUNA 0.00
- ALEC 0.15
- MACD
- AUNA 0.00
- ALEC 0.07
- Stochastic Oscillator
- AUNA 0.00
- ALEC 4.57
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.